INTEGRATED FILING — Other than Banks



General information about company

Scrip code 000000
NSE Symbol IDEALTECHO
MSEI Symbol NOTLISTED
ISIN INE0T9I01011
Name of Company Ideal Technoplast Industries Limited
Type of company SME
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 28-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 14-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Half Yearly
Reporting Quarter Yearly
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment PLASTIC INDUSTRIES
Start date and time of board meeting 28-May-2025   15:30:00
End date and time of board meeting 28-May-2025   15:45:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? No
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? No
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
(III) Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2024-08-01
Indicate Company website link for updated RPT policy of the Company https://www.idealtechnoplast.com/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable


Financial Results — Other than Bank

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Oct-2024 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Revenue From Operations
Revenue from operations 142777000 284795000
Other income 3593000 3639000
Total Income 146370000 288434000
2 Expenses
(a) Cost of materials consumed 112277000 217881000
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -12081000 -16217000
(d) Employee benefit expense 5769000 12760000
(e) Finance costs 3631000 7478000
(f) Depreciation and amortisation expense 3992000 7360000
(g) Other Expenses
1 Other Expenses 4245000 20678000
Total other expenses 4245000 20678000
Total expenses 117833000 249940000
3 Profit before exceptional and extraordinary items and tax 28537000 38494000
4 Exceptional items 0 0
5 Profit before extraordinary items and tax 28537000 38494000
6 Extraordinary items 0 0
7 Profit before tax 28537000 38494000
8 Tax Expense
Current tax 6249000 8216000
Deferred tax 4074000 1473000
Total tax expenses 10323000 9689000
9 Net Profit Loss for the period from continuing operations 18214000 28805000
10 Profit (loss) from discontinuing operations before tax 0 0
11 Tax expense of discontinuing operations 0 0
12 Net profit (loss) from discontinuing operation after tax 0 0
13 Profit (loss) for period before minority interest 18214000 28805000
14 Share of profit (loss) of associates
15 Profit (loss) of minority interest
16 Net profit (Loss) for the period 18214000 28805000
17 Details of equity share capital
Paid-up equity share capital 50000000 50000000
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve 187346000
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 3.75 6.47
Diluted earnings (loss) per share from continuing and discontinued operations 3.75 6.47
20 Debt equity ratio 0.0 0.0
21 Debt service coverage ratio 0.0 0.0
22 Interest service coverage ratio 0.0 0.0
23 Disclosure of notes on financial results


Remarks

20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Cash flow statement — indirect

A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
1 Statement of cash flows
Cash flows from used in operating activities
Profit before extraordinary items and tax 38494000
2 Adjustments for reconcile profit (loss)
Adjustments to profit (loss)
Adjustments for finance costs 7478000
Adjustments for depreciation and amortisation expense 7360000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income -34000
Adjustments for share-based payments 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items -3270000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments to profit (loss) 11602000
3 Adjustments for working capital
Adjustments for decrease (increase) in inventories -12627000
Adjustments for decrease (increase) in trade receivables -21000
Adjustments for decrease (increase) in other current assets -81484000
Adjustments for increase (decrease) in trade payables -4018000
Adjustments for increase (decrease) in other current liabilities 60922000
Adjustments for provisions 0
Total adjustments for working capital -37228000
Total adjustments for reconcile profit (loss) -25626000
Net cash flows from (used in) operations 12868000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 9023000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities before extraordinary items 3845000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) operating activities 3845000
4 Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property plant and equipment 0
Purchase of property plant and equipment 161633000
Proceeds from sales of intangible assets 0
Purchase of intangible assets -120000
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 34000
Interest received 3497000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Proceeds from government grants 0
Net cash flows from (used in) investing activities before extraordinary items -157982000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) investing activities -157982000
Cash flows from used in financing activities
Proceeds from issuing shares 147456000
Proceeds from issuing other equity instruments 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 22782000
Repayments of borrowings 9320000
Dividends paid 0
Interest paid 7478000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities before extraordinary items 153440000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) financing activities 153440000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -697000
6 Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -697000
Cash and cash equivalents cash flow statement at beginning of period 2831000
Cash and cash equivalents cash flow statement at end of period 2134000


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Equity and liabilities
1 Shareholders' funds
Share capital 50000000
Reserves and surplus 187346000
Money received against share warrants 0
Total shareholders' funds 237346000
2 Share application money pending allotment 0
3 Deferred government grants 0
4 Minority interest
5 Non-current liabilities
Long-term borrowings 47164000
Deferred tax liabilities (net) 3322000
Foreign currency monetary item translation difference liability account 0
Other long-term liabilities 0
Long-term provisions 103000
Total non-current liabilities 50589000
6 Current liabilities
Short-term borrowings 72639000
Trade Payables
(A) Total outstanding dues of micro enterprises and small enterprises 5624000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 11185000
Total Trade payable 16809000
Other current liabilities 5005000
Short-term provisions 1676000
Total current liabilities 96129000
Total equity and liabilities 384064000
Assets
1 Non-current assets
i Property, Plant and Equipment and Intangible assets
Property, Plant and Equipment 105493000
Producing properties 0
Intangible assets 0
Preproducing properties 0
Property, Plant and Equipment capital work-in-progress 124059000
Intangible assets under development or work-in-progress 4615000
Total Property, Plant and Equipment and Intangible assets 234167000
ii Non-current investments 0
v Deferred tax assets (net) 0
vi Foreign currency monetary item translation difference asset account 0
vii Long-term loans and advances 0
viii Other non-current assets 0
Total non-current assets 234167000
Current assets
Current investments 0
Inventories 52970000
Trade receivables 11224000
Cash and cash equivalents 2134000
Bank balance other than cash and cash equivalents 0
Short-term loans and advances 0
Other current assets 83569000
Total current assets 149897000
Total assets 384064000
Disclosure of notes on assets and liabilities


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Oct-2024 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments




Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Mode of Fund Raising Public Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 23-Aug-2024
Amount Raised 16032500000000
Report filed for Quarter ended 31-Mar-2025
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review No deviation in utilisation of funds
Comments of the auditors, if any No deviation in utilisation of funds
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 To meet capital expenditure None 13627600000000 0 8627600000000 5000000000000 out of the be unutilised amount Rs. 500 lakhs have been parked under fixed deposits in bank which shall be utilised towards payment for capital assets.
2 General corporate purpose None 804900000000 0 804900000000 0
3 To meet public issue expense None 1600000000000 0 1600000000000 0


Signatory Details

Name of signatory VIPULBHAI DULABHAI MENDAPARA
Designation of person Managing Director
Place Surat
Date 28-May-2025


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
Total value of transaction during the reporting period